Volume 91 Issue 24 | p. 21 | Concentrates
Issue Date: June 17, 2013

Ash Stevens To Make Ariad Drug

Department: Business
Keywords: pharmaceuticals, contract manufacturing, active pharmaceutical ingredient, oncology

Ash Stevens, a Riverview, Mich.-based contract manufacturer, is making the active pharmaceutical ingredient for Ariad Pharmaceuticals’ leukemia drug Iclusig (ponatinib). FDA approved the drug in December 2012 and recently signed off on Ash Stevens’ production process, which incorporates quality-by-design principles. The drug is the first that Ariad developed and commercialized on its own. The drug marks Ash Stevens’ 12th manufacturing approval for a new chemical entity.

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society